Sun Pharma acquires Organon
Sun Pharma agreed to acquire Organon. Reported deal value: $10B. Status: Pending. Sector: pharmaceuticals. Target headquarters context: Jersey City, New Jersey, United States.
This page summarizes publicly available information about the transaction as of 2026-04-27. Figures and status may change as filings and press coverage update.
Sun Pharma Signs Definitive Agreement to Acquire Organon On Apr 27, 2026 Sun Pharma has entered into a definitive agreement with Jersey City -based Organon , to acquire all of the latter company outstanding shares for $14 per share in an all‑cash transaction valued at $11.75 billion
Deal timeline
This transaction is classified in pharmaceuticals with a reported deal value of $10B. Figures and status may change as sources update.